Loading provider…
Loading provider…
Hematology & Oncology Physician in Bronx, NY
NPI: 1013933290Primary Practice Location
MONTEFIORE MEDICAL CENTER
3415 Bainbridge Ave, Bronx, NY
Primary Employer
Montefiore Medical Center
montefioreeinstein.org
HQ Phone
Get MD Balazs's Phone Numberphone_androidMobile
Get MD Balazs's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
NY State Medical License
2009 - 2026
OH State Medical License
2004 - 2010
MA State Medical License
2000 - 2004
Beth Israel Deaconess Medical Center
Fellowship • Hematology and Medical Oncology
1998 - 2001
Icahn School of Medicine at Mount Sinai/Morningside/West
Residency • Internal Medicine
1995 - 1998
Semmelweis University
Medical School
Until 1992
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 62 | 183 |
| 2 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 28 | 90 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 22 | 32 |
| 4 | 99221Initial hospital inpatient care, typically 30 minutes per day | 19 | 19 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 14 | 16 |
Authors: Avrum Spira
Journal: Am J Respir Crit Care Med
Immunotherapy for metastatic non-small cell lung cancer: Is it really a no-brainer?
Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells.
Authors: Agarwal, Banke, Halmos, Balazs, Feoktistov, Aleksander S, Protiva, Petr, Ramey, William G, Chen, Ming, Pothoulakis, Charalabos, Lamont, J Thomas, Holt, Peter R
Journal: Carcinogenesis
Lead Sponsor: Columbia University
Intervention / Treatment: OTHER: Apricity C.A.R.E. Program for Cancer Adverse events Rapid Evaluation
Lead Sponsor: Black Diamond Therapeutics, Inc.
Intervention / Treatment: DRUG: silevertinib (BDTX-1535) monotherapy
Lead Sponsor: Montefiore Medical Center
Collaborators: National Cancer Institute (NCI), The Leukemia and Lymphoma Society, Albert Einstein College of Medicine
Intervention / Treatment: BIOLOGICAL: BNT162b2 vaccine